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Å kjenne til sammensetningen av makronæringsstoffer som fett og proteiner er nødvendig for 
å forstå eventuelle helsemessige effekter av ulike matvarer. Forskning på marine matvarer har 
i stor grad vært rettet mot lipider og helserelaterte effekter av disse. Anbefalt daglig inntak av 
eicosapentaenoic acid (EPA) og docosahexaenoic acid (DHA) er 0,2 til 0,5g/dag, noe man 
kan oppnå med to porsjoner fet fisk i uken. Men også sammensetningen av proteiner og 
forholdet mellom de forskjellige aminosyrene har betydning for de helsemessige effektene av 
næringsmidler. Kjennskap til aminosyresammensetningen viser seg derfor å være et viktig 
aspekt for å kunne forklare de helsemessige effektene forbundet med enkelte næringsmidler. 
Ved enzymatisk hydrolyse i fordøyelsen kan man få dannet peptider med biologiske 
aktiviteter, for eksempel blodtrykkssenkende peptider og peptider med antioksidativ kapasitet.  
 
Hovedmålet med denne oppgaven har vært å fastslå sammensetningen av lipider og 
aminosyrer, i tillegg til vann og askeinnhold i blåskjell og kamskjell. Evnen til å hemme 
angiotensin converterende enzym (ACE) ble også undersøkt. I tillegg ble det undersøkt 
hvilken effekt to ulike typer tilberedning hadde på de ulike faktorene.  
 
Resultatene viste en tydelig forskjell i mengde aminosyrer og lipider, og ulik sammensetning 
av aminosyrer mellom de to artene. Lipidsammensetningen var ulik for de to artene, men 
begge hadde en typisk marin lipidprofil med høy mengde EPA og DHA. Koking viste seg å 
ha større effekt på sammensetningen enn hurtig steking. ACE-hemming var kun påvirket av 
koking, men så ikke ut til å påvirkes av tilberedning når man justerte for proteininnhold.  
 
Konklusjonen er at både kamskjell og blåskjell er gode kilder til EPA og DHA, gode 
proteinkilder med stor mengde essensielle aminosyrer. Kamskjell og blåskjell har ACE-








Knowing the composition of macronutrients such as fats and proteins are necessary for 
understanding the potential health effects of various foods. Research on marine foods have 
largely been directed towards lipid and health effects of these. The recommended daily intake 
of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is 0.2 to 0.5 g / day, which 
that can be achieved with about two servings of fatty fish a week. But also the composition of 
proteins and the relationship between the different amino acids are important for the health 
effects of foods. Knowledge of amino acid composition appears therefore to be an important 
aspect in order to explain the health effects associated with certain foods. During the 
enzymatic hydrolysis in the digestion process peptides with biological activities can be 
formed, such as antihypertensive peptides and peptides with anti-oxidative capacity. 
 
The main objective of this study was to determine the composition of lipids and amino acids, 
in addition to water and ash content in mussels and scallops. The ability to inhibit 
angiotensin-converter enzyme (ACE) was also investigated. In addition, the effects of 
household preparation on the various factors was investigated. 
 
The results showed a clear difference in the amount of amino acids and lipids, and the 
different composition of amino acids between the two species. Lipid composition was 
different for the two species, but both had a typical marine lipid profile with high amounts of 
EPA and DHA. Boiling appeared to have greater effect on the composition than panfrying. 
ACE inhibition was only affected by boiling, but when adjusted for protein content this effect 
was not significant. 
 
The conclusion is that both the scallops and mussels are good sources of EPA and DHA, good 
sources of protein with a large proportion of essential amino acids. Scallops and mussels have 
ACE-inhibitory effect and the effect appears to be related to the amount of protein. 
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Cardiovascular disease (CVD) is the leading cause of death in the world. According to the 
WHO ischaemic heart disease and stroke constitute 12 and 10 percent, respectively, of 
worldwide deaths every year (WHO 2011). Elevated blood pressure (BP), or hypertension, is 
seen as one of the most important risk factors for developing CVD, and a reduction in BP in a 
population is assumed to have a significant impact on development and mortality of CVD 
(Rédei 2008). Despite great therapeutic advances the prevalence of hypertension is increasing 
(Chobanian 2009).  
 
While blood pressure lowering drugs are generally accepted as safe and effective they are not 
without side effects. For patients with mild hypertension, alternative methods of reducing BP 
such as diet, activity and naturally occurring compounds are therefore preferred. It is therefore 
of great interest to further explore food items and bioactive compounds that can have a 
beneficial effect on human health.  
 
The interest for marine bioprospecting is rapidly increasing. The marine environment is not 
well explored in this regard, compared to terrestrial species. Marine animals have unique 
challenges in their environment and contain a variety of diverse molecules that are used to 
deal with the environoment they are exposed to (Chin, Balunas et al. 2006).  
 
Bivalves are a large group of mollusks, currently numbering around 9200 different species, 
the majority of which are filter feeders. A high amount of n-3 PUFA, taurine and the 
possibility of novel bioactive molecules make bivalve mollusks an interesting group of 
animals for marine bioprospecting. 
 
The purpose of this study was to look at proximate composition of two different species of 
bivalve mollusks, blue mussels (Mytilus edulis) and scallops (Pecten maximus).  Their ability 
to inhibit angiotensin converting enzyme (ACE) was also tested. Finally the effects of normal 




Blood pressure and cardiovascular disease 
 
Cardiovascular disease  
 
CVD is the biggest contribution to total healthcare expenditures in USA, direct and indirect 
cost for CVD and related conditions was around 297 billion in 2008. Between 2012 and 2030 
these cost are projected to triple. A reduction in CVD will therefore have a great economic 
impact (Roger, Go et al. 2012). 
 
Some of the risk factors associated with CVD such as increased age, gender and genetic 
predispositions are not possible to change. The most common modifiable risk factors affecting 
arteries are cigarette smoking, hypertension, and hypercholesterolemia (Wong, Wilson et al. 
1991). 
 
Atherosclerosis is a disease affecting elastic arteries. Coronary, carotid, cerebral, renal arteries 
and the aorta are often affected. Atherosclerotic plaques consist of fat, cholesterol, various 
inflammatory cells and other substances. These plaques can cause problems with blood flow 
in the affected area, or they can break loose and cause stenosis or thrombosis in other organs 
in the body. Although the obvious consequence of plaques seems to be the mechanical effect 
on blood flow other risk factors are associated with them. A high degree of inflammatory cells 
in plaques seem to increase the risk of fatal events. Certain drugs like statins are also able to 
reduce clinical events associated with established atherosclerosis without reducing the size of 
plaques (Cohen and Rudd 2006a) 
 
The primary event in the formation of atherosclerotic plaques is probably endothelial 
dysfunction, damage to endothelial cells can lead to lipid accumulation. Endothelial cells 
synthesize nitrogen oxide (NO) which works as a powerful inhibitor of platelet aggregation 
and has anti-inflammatory properties. If the endothelium breaks down it become more 
adhesive to inflammatory cells and platelets. Endothelial function is improved by certain 





The link between hypertension and CVD 
 
Hypertension is often seen in combination with other cardiovascular risk factors such as 
diabetes mellitus, hyperinsulinemia, dyslipidemia, inflammation and endothelial dysfunction 
and obesity(Cachofeiro, Miana et al. 2009; Cassis and Police 2010; Zhang, Thompson et al. 
2010). The risk of coronary artery disease more than doubles among patients with 
hypertension and dyslipidemia, when compared to those with either condition alone. A history 
of smoking and use of alcohol also contribute to cardiovascular morbidity (Criqui, Mebane et 
al. 1982; Johnson, Pietz et al. 2004). The connection between glucose metabolism and 
hypertension is well known in animal models. The best known example is fructose induced 
hypertension in rat (Hwang, Ho et al. 1987; Tran, Yuen et al. 2009). Human studies have 
shown that improvement of insulin sensitivity has a positive effect on blood pressure 





The Renin-angiotensin-aldosterone-system (RAAS) plays an important role in the 
cardiovascular system, controlling extracellular fluid volume, sodium excretion, and other 
vascular effects. RAAS over activity is associated with hypertension, atherosclerosis and 
other CVD (Widmaier 2007).  
 
Renin converts the inactive angiotensinogen to angiotensin I (AngI). The zinc metallo-
peptidase Angiotensin-I-converting-enzyme (ACE) will form angiotensin II (AngII) by 
removing the dipeptide His-Leu from AngI. AngII is a powerful vasoconstrictor, and will 
promote sodium retention by increasing tubular reabsorption of sodium. RAAS systems are 
found in various tissues in the body. Kidneys, heart, brain and vessels contain angiotensin that 
are either expressed locally or imported from the circulation (Bader 2010). In the kidneys, 
AngII is formed from systemically delivered angiotensinogen and AngI, as well as from 
locally produced angiotensinogen. Transgenic mice who overexpress AngII in the kidneys 
develop hypertension and renal injury without increasing circulating AngII. This effect means 
ACE-inhibitors can lead to decreased BP by reducing local AngII production without 




Angiotensin II is, in addition to sodium retention and vasoconstriction, a promotor of 
inflammatory substances and oxidative stress in kidneys and vascular tissues. There is also 
evidence showing that increasing oxidative stress in animals can cause up-regulation of AngII 
and hypertension (Vaziri and Rodriguez-Iturbe 2006).  In normal physiological situations 
(non-pathological) production of AngII in the RAAS does not lead to oxidative stress or 
inflammation. Increased levels of AngII in a high sodium diet led to oxidative stress in rats 
(Kitiyakara, Chabrashvili et al. 2003). In humans oxidative stress and inflammation resulting 





ACE affects the kinin-kallikrein system by degrading kinin, which is a vasodilating substance. 
ACE-inhibitors can therefore reduce hypertension by increasing kinin concentration. Kinin 
has known cardio- and renal protective actions and might be responsible for some of the 







Its estimated that blood-pressure related disease causes the death of about 8 million people a 
year, the majority of cases occur in low-income and middle-income countries (Abegunde, 
Mathers et al. 2007).  Despite a high amount of blood-pressure related diseases compared to 
high-income countries, low and middle-income countries have access to less than 10% of 
global treatment resources (Lawes, Hoorn et al. 2008; MacMahon, Alderman et al. 2008). 
 
Blood-pressure (BP) involves two measurements, systolic and diastolic.  BP in the range 90-
119 mm/hg systolic and 60-79 mm/hg diastolic is considered as normal. Anything above 
140/90 is defined as hypertension. Blood-pressure between these stages is referred to as pre-
hypertension.  In the human body BP is regulated by cardiac output (CO) and peripheral 
resistance (PR). CO is adjusted by heart rate and stroke volume, PR is adjusted by the changes 
in smooth muscle in arteries and arterioles (Widmaier 2007). 
 
Hypertension can be divided into primary hypertension, and secondary hypertension. Primary 
is the most common in adults. It has no identifiable distinct cause and can develop over a 
course of several years. Secondary hypertension is a result of some underlying condition or 
can be caused of certain medications. It appears suddenly and can result in higher BP than 
primary hypertension (Cohen and Rudd 2006c). Although there is no distinct cause for 
primary hypertension there are several factors associated with chronic elevation in BP, such 
as smoking, obesity, sedentary lifestyle, sodium sensitivity and high level of alcohol 
consumption among others (Forman, Stampfer et al. 2009). 
 
Hypertension can be seen as a distinct disease or as a major risk factor for cardiovascular 
disease, it contributes directly to artery disease, stroke, congestive heart failure, renal failure, 
and peripheral arterial disease. Successful reduction of BP and other cardiovascular risk 
factors can dramatically reduce the incidence of coronary mortality, especially for those with 
multiple risk factors and the elderly (Stamler, Stamler et al. 1989; Mac Mahon and Rodgers 
1993). 
 
BP is strongly related to CVD during middle and older age. Of the known cardiovascular risk 
factors, hypertension is the most common. The prevalence increases with age, for adults over 
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65 BP-lowering drugs are among the most common prescription drugs (Sarah, Robert et al. 
2002; Cohen and Rudd 2006c).  
 
If left untreated hypertension can lead to damage on various organs in the body. Common 
organs that are affected by hypertension are: heart (diastolic dysfunction, left ventricular 
hypertrophy, endothelial scarring), large and medium sized arteries (accelerated 
atherosclerosis, aneurism formation), brain (ischemia, hemorrhagic and thrombotic 











Management of hypertension 
 
Management of hypertension can be done in several ways. The different methods can be 
classified as non-pharmacological and pharmacological. Non-pharmacological involves diet, 
lifestyle changes and exercise. While non-pharmacological methods may prevent 
hypertension, combining non-pharmacological and pharmacological has the best effect at 
reducing BP (Cohen and Rudd 2006c).  
 
Hypertension is a condition that can be influenced by diet and lifestyle, and a modest 
reduction of BP can greatly reduce the risk of CVD. In a larger population a very small 
reduction in average BP will greatly affect number of deaths per year due to CVD. Therefore 
any food item that can lover BP should be considered a possible component of a diet that has 





Pharmacological treatment is useful if non-pharmacological methods alone are not sufficient 
at reducing BP, or if patients are showing signs of CVD, target organ damage or stage 2 
hypertension. Drugs used for controlling BP can be divided into following groups: Diuretics, 
antiadrenergics, ACE inhibitors, angiotensin receptor blockers, calcium antagonists and direct 
vasodilators (Cohen and Rudd 2006c).  
 
The effect of ACE inhibitors as treatment for hypertension is well known, and is regarded as a 
safe and efficient way of reducing BP (Frank 1989). There are however side effects associated 
with drugs, and they might not be an optimal solution for people with pre-hypertension (Izzo 
2007). The adverse effects of ACE inhibitors include first-dose hypotension, renal 
dysfunction, hyperkalemia, and persistent dry cough. Because of effects on the fetus it is not 
recommended to use during pregnancy (Alderman 1996). Due to side effects associated with 




Non- Pharmacological therapy 
 
Diet plays an important role in the prevention and management of CVD. In the case of 
hypertension it is recommended to reduce sodium intake, increase intake of fruits, vegetables 
and low-fat dairy. If needed, weight reduction and exercise is also recommended (Cohen and 
Rudd 2006b). 
 
There have been three large studies focused on macronutrient intake on blood pressure and 
blood lipids. The Dietary Approaches to Stop Hypertension (DASH), DASH – Sodium, and 
Optimal Macro-Nutrient Intake to Prevent Heart Disease (Omniheart diet). All of these 
studies tested the effect of different macronutrient ratios on CVD markers while maintaining a 
stable bodyweight (Miller, Erlinger et al. 2006). The diets were very successful at reducing 
BP. Hypertensive subjects in the DASH trial had a reduction of 11.4 mm Hg and 5.5 mm Hg 
systolic and diastolic BP respectively (Appel, Moore et al. 1997). 
 
Naturally occurring ACE-inhibitory peptides is one alternative method for treating 
hypertension. The safety of these molecules makes it an interesting alternative to existing 
therapies.  
 
The focus in this paper will be on diet, especially the effect of seafood on hypertension and 
the role of natural occurring ACE-inhibitors in management of hypertension. 
 
 
Bioactive proteins and health 
 
Certain proteins and peptides can have biological effects that are not due to the individual 
constituting AA. Bioactive proteins and peptides can be divided into different groups 
depending on their functionality. Opioids, mineral – binding peptides, anti – oxidative 
peptides, antimicrobial peptides, immune – and cyto – modulatory peptides as well as enzyme 
inhibiting peptides (Walther and Sieber 2011). The type of peptide that is formed depends on 
two factors; type of AA sequence in the protein and the enzyme(s) used to generate the 
peptides. Presence of certain AA are associated with certain biological activities. Binding to 
ACE is for instance strongly influenced by the presence of tyrosine, phenylalanine, 
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tryptophan, proline, lysine, isoleucine, valine, leucine, and arginine (Harnedy and FitzGerald 
2011).  
 
Absorption of bioactive proteins over the GI tract is limited due to the size of the proteins, 
current knowledge indicates that mainly dipeptides and tripeptides can cross the intestional 
wall and enter the blood. Larger bioactive peptides and proteins can have activity in the GI 
tract itself by enhancing nutrient absorption, inhibiting enzymes and modulating the immune 
system (Federal commission for nutrition 2011). Peptides with proline and hydroxyproline are 
generally more resistant to digestive enzymes, and may therefore have a better chance of 





Several studies on hypertensive rats and humans have shown ACE-inhibitory (ACEI) peptides 
to be effective at reducing blood pressure. The peptides in these studies had little or no effect 
on normotensive subjects (Erdmann, Cheung et al. 2008). The first commercial product 
containing ACEI-peptides was a milk based drink containing lacto-tripeptides. It was first 
sold in Japan in 1991. Some of the best documented ACE-inhibitory peptides found in 
fermented milk are isoleucine-proline-proline (IPP, IC50 = 5µmol/L), and valine-proline-
proline (VPP, IC50 = 9µmol/L) (Boelsma and Kloek 2009). 
 
Lactopeptides are considered safe. Even in very large doses they had no adverse effect on rats. 
Milk proteins are a normal part of a human diet in the Western world, and humans are 
regularly exposed to their hydrolyzed products either by digestion or consumption of 
fermented products (Boelsma and Kloek 2009). 
 
Marine organisms are an interesting source of biologically active compounds and are still 
relatively unexplored in this regard compared to other protein-rich foods. Potent ACE-
inhibitors have been found in marine sources, and it’s of great interest to isolate other similar 
compounds (Wijesekara and Kim 2010). In vitro potency of marine peptides are comparable 
to the two lacto-tripeptides IPP and VPP present in commercially sold beverages (Howell and 




Taurine and CVD risk factors 
 
In addition to the essential AA, methionine, sulfur-containing AA (methionine, cysteine, 
homocysteine and taurine) are important. Sulfur AA are used in many physiological 
pathways, glutathione production, protein synthesis and methylation (Brosnan and Brosnan 
2006). 
 
Taurine (2-aminoethanesulfonicacid) is an amino acid that does not participate in the 
formation of peptide bonds, and is therefore only found as a free amino acid. Taurine is 
counted as a conditionally essential AA. The main source of taurine is through diet, but small 
amounts can be synthesized from methionine and cysteine (Mark 2005).  
 
Taurine is necessary for several biological functions such as bile acid conjugation, cell 
membrane stabilization, development of the central nervous system and retina, 
osmoregulation, modulation of cellular calcium and the immune system. Taurine can also 
have some effect on regulation of blood pressure, antioxidative capacity, anti-inflammatory 
effects and cholesterol lowering effects. It might have an effect on CHD, but the data on 
humans is limited (Harnedy and FitzGerald 2011). 
 
 
Taurine and blood pressure 
 
Epidemiological studies have shown an inverse relationship between urinary taurine excretion 
and CVD risk and mortality in humans (Moriguchi, Moriguchi et al. 2004; Yamori, Liu et al. 
2009).  These findings are supported by studies on spontaneously hypertensive rats (SHR) 
(Nandhini and Anuradha 2004; Hu, Xu et al. 2009; Yamori, Taguchi et al. 2010), and studies 






n-3 FA and blood pressure 
 
Several studies have shown an association between n-3 PUFA and a reduction in blood 
pressure. However the effects seen are modest, and doses used to achieve this tend to be high, 
≥3g per day. The observed effects are greater in older individuals, ≥45 years. No effect has 
been observed on normotensive subjects. Proposed mechanisms for reduction in BP are 
reduced production of thromboxane A2, increased nitric oxide (NO) production, improved 
vascular compliance and an effect on autonomic nerve function (Saravanan, Davidson et al. 
2010). A recent review confirmed this by finding small but statistically significant BP-
lowering effects of fish oil supplements (Campbell, Dickinson et al. 2012). Marine n-3 can 
also be used in combination therapy against hypertension. About one gram of n-3 PUFA used 
in combination with diuretics and beta-blockers by hypertensive patients gave a reduction of 3 
mmHg DSP and 2 mmHg SBP, showing that n-3 PUFA can be a useful addition to 
pharmacological therapy, even if the effect is only a modest reduction. There was also a 21% 
reduction of plasma triglycerol and an 15% increase in HDL cholesterol in the group 






Materials and Methods 
 
Design of study 
 
 
Two species of bivalve mollusks, blue mussels (Mytilus edulis) and scallops (Pecten 
maximus) were investigated in this study.Blue mussels and scallops were purchased from 
Dragøy AS (Tromsø, Norway)  
 
To examine the effect of preparation scallops and mussels were divided into four subgroups; 
raw mussels, prepared mussels, raw scallops and prepared scallops. Each subgroup was 
divided into 5 batches. Weight and yield of the various subgroups are described in table 1. 
 
Blue mussels were steamed until all the mussels were open (2:15 – 2:45 minutes) and scallops 
were fried at high temperature, without butter or oil, for about one minute on each side. The 
preparation methods are the most commonly used for the two species, steaming for blue 
mussels and panfrying for scallops, respectively. Both raw and prepared samples were 
subsequently homogenized and frozen. Due to a large and variable water content the samples 
were freeze dried. Both species were freeze dried (VirTis Genesis 35L) until constant weight. 
The samples were homogenized to a fine powder using a grinder (MF 10 basic, IKA werke) 
and stored in the dark at room room temperature. The samples were subjected to a simulated 






Water and ash content 
 
The water content was determined according to AOAC method 950.46b (Horwitz 2004). 2 
grams of freeze dried sample was dried at 105° C until constant weight.  
 
Ash content was determined according to AOAC method 938.08 (Horwitz 2004). The dried 
samples were combusted at 500° C for 12 hours.  
 
 
Protein content and amino acid composition  
 
Free amino acids (FAA) were prepared by homogenizing 0.2 gram of freeze dried material in 
9 ml dH2O and 1 ml 20 mM nor-leucine (N-leu) as an internal standard. The sample was 
homogenized for 15 seconds using an Ultra turrax (T25 basic, ICA werke), 1 mL 35% 
sulfosalicylic acid (SSA) was added and the sample was homogenized for another 15 seconds.  
The sample was centrifuged at 20.000 rpm for 10 minutes, 4°C. The supernatant (0.2 ml) was 
transferred to an analyzing tube and 0.8 ml lithium citrate buffer (pH 2.2) was added. 
 
Total amino acids were prepared by homogenizing 40 mg of freeze dried material in 700 µL 
H2O and 1.2 ml Hydrochloric acid (HCL). 500 µL 20mM N-leu was added as an internal 
standard. The samples were flushed with N2 for 10 seconds to prevent oxidation. The sample 
was hydrolyzed at 105°C for 22 hours. The supernatant (0.1 ml) was dried using N2 gas and 
1.0 ml lithium citrate buffer (pH 2.2) was added.  
 
The amino acids were analyzed chromatographically using an ion exchange column. Buffers 
with different pH and ionic strength were used according to Spackman et al (1958), and 
compounds were detected by UV-light after post-column derivatization with ninhydrin.  The 
machine used was a Biochrom 30 amino acid analyzer (Biochrom Co, Cambridge, UK). The 
UV-signals were analyzed with Chromeleon software (Dionex, sunnyvale CA, USA), and 
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Protein content was calculated from amino acid content using the following formula: 
 




The total lipid content was analyzed using a method described by Folch et al (1957), the 
chloroform was substituted with dichloromethane for safety reasons. 1 gram sample was 
mixed with 20 ml dichloromethane/methanol (2:1 v/v) and mixed for 20-30 minutes. The 
samples were filtrated and 4 ml 0.9% NaCl was added before the sample was centrifuged at 
2000 rpm at 4°C for 10 minutes. The upper, water-soluble layer was removed, and the lower 
lipid phase was transferred to a round-bottomed flask and dried using an evaporator (RV 10, 
IKA werke) (400 mbar 40°C). The lipid content was calculated gravimetrically.  
 
Fatty acid composition 
 
The sample was methylated by method described by Stoffel et al (1959), with some 
modifications. Dichloromethane/methanol was added to make an concentration of 10mg lipid 
per ml. 100 µL of sample was mixed with 900 µL dichloromethane and 2 ml 2% H2SO4 in 
methanol. The mixture was then boiled for one hour. 3.5 ml heptane and 3.5 ml 5% NaCl was 
added. The heptane phase was transferred to glass tubes and dried using N2 gas. The sample 




The FA profile was determined by gas chromatography, using an Agilent 6890N with a 
7683B autoinjector and flame ionization injector (FID) A predefined temperature program 
was used (50°C for two minutes, then a 10°C per minute increase till 150°C, 2°C per min till 
205°C and 15°C till 255°C followed by stabilization for 10 minutes). Some samples were run 
on a slightly different program to see if separation could be improved, but the FA composition 
did not differ between the two programs. The FA profile was compared to known standards: 





Simulated digestion was performed according to Dragnes (2008). Enzymatic hydrolysis was 
performed using the following enzymes: pepsin (Sigma P6887), trypsin (Sigma T4665), and 
chymotrypsin (Sigma C4129). The relationship between the sample and amount of enzyme 
used was 1:250 for all enzymes (0.05g enzyme: 12.5g sample). Samples were mixed with 
water and pH was adjusted to 2 to simulate conditions in the stomach. Pepsin was added and 
the sample was kept at 37°C on a magnetic stirrer for two hours. To simulate the intestinal 
phase the pH was adjusted to 6.5 before trypsin and chymotrypsin was added. The mixture 





ACE-assay was performed according to Dragnes (2008). 200 mg of digested sample and 10 
ml of borate buffer (pH 8.3) was mixed. Dilution series of 2.0, 1.2, 1.0, 0.8, 0.6, 0.4, 0.2 and 
0.1µg/µl was prepared in borate buffer and 25µl was transferred to a 48 well titer plate, giving 
end concentrations of 50, 30, 25, 20, 15, 10, 5 and 2.5 µg. 100 µL of N-hippuryl-Histidyl-
Leucine-tetrahydrate (HHL) was added to each well. Borate buffer was used as a standard. 
The plate was incubated for 30 minutes at 37°C.  
After incubation, 50 µL (1mU/10µL) of Angiotensin converting enzyme (ACE) was added, 








The method used was a modified version of Wu et al (2002). The analysis was performed 
using a Waters 2695 separation module equipped with a Waters 2996 photodiode detector 
(Waters Corporation, MA, USA), using a Symmetry Shield reverse phase column (Waters 20 
x 3.0 mm id 3.5 µm). The mobile phases used were 0.05% trifluoroacetic acid (TFA) in dH2O 
and acetonitrile (ACN) at 30°C. A 2 minute linear gradient was used, flow rate was set at 2.0 
ml/min. UV-detection was set at 228nm, and injection volume was 10µL Identification of HA 
and HHL was performed using the software Millennium (Waters Corporation, MA, USA). 
 
ACE-inhibition was determined as IC50, or the amount of material that would inhibit 50 





Statistics were performed using SPSS 19.0 (SPSS Inc, Chicago, Il, USA). An independent T-
test was used to compare two variables. A P-value of less than 0.05 was considered significant 






Shell and edible content 
 
Table 1 - Shell weight and weight of edible tissue in blue mussels and scallops. Weight is the average for each 
subgroup ± standard deviations. 
  Blue mussels, raw Blue mussels, cooked Scallops, raw Scallops, cooked 
  
Average weight per batch (g) 
 Number of batches 5 5 5 5 
Weight with shell 486.0 ± 24.8 485.6 ± 25.4 531.6 ± 33.7 526.5 ± 24.8 
Weight without shell 175.5 ± 43.3 128.3 ± 31.5 73.8 ± 3.7 66.2 ± 6.7 
Yield % 35.9 ± 8.2 26.5 ± 6.3 13.9 ± 0.4 12.6 ± 1.3 
 
 
Mussels contained more edible tissue than scallops, and the difference in yield was greater 
between raw and cooked mussels than scallops.  
Proximate composition 
 
Table 2 shows the proximate composition in wet weight mussels and scallops. There was a 
significant difference between water, protein, and lipids between raw and steamed mussels. In 
scallops there was a small but significant difference in water, protein and ash after 




Table 2 - Water, protein, lipids and ash in wet weight mussels and scallops (n=5). Values are given as mean ± standard 
deviations. ¤ indicates significant difference between raw and cooked mussels, * indicates a significant difference 
between raw mussels and raw scallops, † indicates a significant difference between raw scallops and cooked scallops. 
  Blue mussels, raw Blue mussels, cooked Scallops, raw Scallops, cooked 
 
g/100g 
Water 82.2 ± 1.4  78.0 ± 0.8 ¤ 78.0 ± 0.6 * 76.0 ± 0.4 † 
Protein 5.2 ± 0.2  8.1 ± 0.2 ¤ 11.4 ± 0.2 * 12.8 ± 0.1 † 
Lipids 1.3 ± 0.2  1.8 ± 0.3 ¤ 0.5 ± 0.2 * 0.6 ± 0.1  









In mussels free AA was significantly reduced and total AA was significantly increased after 
preparation. The change in sulfur-containing AA was non-significant. In scallops there was 
almost no significant difference in AA content between raw and prepared samples. The only 
difference was a small but significant change in free alanine and total cysteine after 
preparation. 
 




Table 3 – Free amino acids in raw and prepared blue mussels and scallops (n=5). Values are given as a mean ± 
standard deviations and in mg/g sample (dry weight).  ¤ indicates significant difference between raw and cooked 
mussels, * indicates a significant difference between raw mussels and raw scallops, † indicates a significant difference 
between raw scallops and cooked scallops.   n.a = not analyzed.  n.d = not detected. EAA = essential amino acids. 
  Blue mussels raw Blue mussels, cooked Scallops, raw Scallops, Cooked 
EAA   mg/g   
Histidine 1.3 ± 0.2 1.1 ± 0.2 n.d n.d 
Isoleucine 0.6 ± 0.0 0.5 ± 0.1 ¤ n.d n.d 
Leucine 0.9 ± 0.1 0.7 ± 0.1 ¤ n.d n.d 
Lysine 2.9 ± 0.9 2.4 ± 0.2 n.d n.d 
Methionine 1.1 ± 0.1 0.7 ± 0.1 ¤ n.d n.d 
Phenylalanine 0.8 ± 0.1 0.6 ± 0.1 ¤ n.d n.d 
Threonine 2.0 ± 0.2 1.4 ± 0.0 ¤ n.d n.d 
Tryptophan n.a n.a n.a n.a 
Valine 1.2 ± 0.1 0.8 ± 0.1 n.d n.d 
Sum EAA 10.7 ± 0.6 8.2 ± 0.5 ¤ n.d n.d 
     Non-EAA 
    Arginine 3.9 ± 1.0 4.3 ± 0.5 14.4 ± 3.8 * 13.5 ± 2.8 
Cysteine 0.6 ± 0.2 0.4 ± 0.1 n.d n.d 
Glutamine 2.1 ± 0.1 2.0 ± 0.3 n.d n.d 
Glycine 11.5 ± 0.4 9.7 ± 0.5 ¤ 67.5 ± 2.2 * 66.2 ± 2.9 
Tyrosine 1.4 ± 0.1 1.1 ± 0.1 ¤ n.d n.d 
Alanine 15.2 ± 0.8 10.7 ± 0.9 ¤ 3.7 ± 0.9 * 2.6 ± 0.4 † 
Taurine 26.5 ± 1.8 22.1 ± 0.9 ¤ 44.3 ± 4.4 * 47.3 ± 2.6 
B-Alanine 1.1 ± 0.2 0.9 ± 0.1 n.d n.d 
Aspartic acid 1.7 ± 0.3 1.9 ± 0.1 n.d n.d 
Glutamic acid 6.0 ± 3.4 6.1 ± 0.4 n.d n.d 
Proline 3.2 ± 0.3 2.6 ± 0.4 ¤ n.d n.d 
Serine 5.1 ± 1.1 4.1 ± 0.4 n.d n.d 
Ornithine 0.3 ± 0.0 0.3 ± 0.1 ¤ n.d n.d 
Sum Non EAA 78.5 ± 4.1 66.2 ± 3.4 ¤ 129.9 ± 5.8 * 129.6 ± 4.7 
     Sum AA 89.2 ± 4.2 74.3 ± 3.9 ¤ 129.9 ± 5.8 * 129.6 ± 4.7 
Sulfuric AA 28.1 ± 0.7 23.3 ± 0.4 ¤ 44.3 ± 4.4 * 47.3 ± 2.6 
UREA 67.2 ± 5.4 49.1 ± 9.4 ¤ n.d n.d 







Table 4 - Free amino acids in raw and prepared blue mussels and scallops (n=5). Values are given as a mean ± 
standard deviations and in mg/g sample (dry weight). ¤ indicates significant difference between raw and cooked 
mussels, * indicates a significant difference between raw mussels and raw scallops, † indicates a significant difference 
between raw scallops and cooked scallops. n.a = not analyzed. n.d = not detected. EAA = essential amino acids. 
  Blue mussels raw Blue mussels, cooked Scallops, raw Scallops, Cooked 
EAA   mg/g   
Histidine 8.6 ± 0.3 9.6 ± 0.3 ¤ 9.3 ± 0.3 * 9.4 ± 0.3 
Isoleucine 14.6 ± 0.7 18.1 ± 0.8 ¤ 24.6 ± 1.0 * 24.9 ± 1.1 
Leucine 23.9 ± 1.2 29.7 ± 1.4 ¤ 46.5 ± 1.5 * 48.3 ± 1.9 
Lysine 30.0 ± 0.9 36.2 ± 1.7 ¤ 49.8 ± 1.5 * 51.0 ± 1.6 
Methionine 8.6 ± 0.4 7.8 ± 3.9 17.1 ± 0.7 * 17.8 ± 0.9 
Phenylalanine 11.9 ± 6.0 17.9 ± 0.7 21.8 ± 0.6 * 22.0 ± 1.0 
Threonine 20.2 ± 0.9 24.0 ± 1.0 ¤ 25.1 ± 1.0 * 26.1 ± 1.1 
Tryptophan n.a n.a n.a n.a 
Valine 13.1 ± 6.6 19.3 ± 0.9 23.8 ± 1.2 * 23.3 ± 1.4 
Sum EAA 130.9 ± 12.3 162.6 ± 9.0 ¤ 217.9 ± 7.8 * 222.9 ± 10.1 
     Non-EAA 
    Arginine 26.0 ± 1.3 32.2 ± 1.8 ¤ 54.9 ± 4.3 * 55.8 ± 4.1 
Cysteine 3.8 ± 0.3 4.9 ± 0.4 ¤ 2.5 ± 0.2 * 3.2 ± 0.3 † 
Glycine 29.5 ± 1.3 32.0 ± 0.9 ¤ 91.2 ± 2.4 * 89.8 ± 3.0 
Tyrosine 12.1 ± 3.4 16.3 ± 0.8 ¤ 17.7 ± 0.8 * 18.6 ± 1.0 
Alanine 30.7 ± 1.7 31.7 ± 1.3 35.5 ± 1.2 * 36.0 ± 1.9 
Taurine 26.0 ± 2.4 22.8 ± 2.4 ¤ 45.5 ± 3.4 * 46.8 ± 2.4 
Aspartic acid 27.3 ± 0.8 33.9 ± 1.3 ¤ 43.4 ± 1.7 * 44.9 ± 1.6 
Glutamic acid 52.0 ± 3.2 60.4 ± 2.2 93.1 ± 3.4 * 96.4 ± 3.7 
Proline 17.3 ± 1.1 19.9 ± 1.8 ¤ 15.5 ± 1.0 * 15.8 ± 1.2 
Serine 22.4 ± 1.0 26.3 ± 0.8 ¤ 28.4 ± 1.2 * 29.3 ± 1.3 
Sum Non EAA 247.0 ± 29.2 280.3 ± 7.9 ¤ 427.9 ± 16.0 * 437.3 ± 17.6 
     Sum AA 377.9 ± 34.6 442.9 ± 15.3 ¤ 645.8 ± 23.7 * 659.6 ± 27.2 
Sulfuric AA 38.3 ± 3.2 35.4 ± 3.3 65.2 ± 4.4 * 67.7 ± 3.2 
UREA n.d n.d n.d n.d 








The lipid content in raw blue mussels ranged from 1.09 to 1.77 g/100g. Steamed mussels had 
a slightly higher fat percentage than raw, ranging from 1.41 to 2.27 g/100g.  The difference 
between raw and prepared samples was significant. The amount of fat in scallops was very 
low, 0.52 and 0.58 g/100g in raw and prepared scallops, respectively. The difference between 
raw and prepared was not significant.  
 
Palmitic acid (C16:0) and palmitoleic acid (C16:1 n-7) accounted for a significant proportion 
of the FA in mussels, over 30 percent combined. The other big contributors were EPA (C20:5 
n-3) and DHA (C22:6 n-3), which accounted for 22 and 12 percent of total fatty acids, 
respectively. Scallops also had a large percentage of palmitic acid, but little palmitoleic acid. 
EPA and DHA contributed to about 45 percent of the total FA.  
 
There was a small, but significant difference in certain FA after processing in mussels. Total 
amount of SFA, MUFA, PUFA, n3 and LC-n3 was not significantly affected by processing. 
In scallops, C22:5n3 and C22:6n3 was significantly increased after processing, which resulted 
in a significant increase in PUFA, n3 and LC-n3 Most FA was significantly different when 
the two species were compared. Preparation had little effect on FA composition in either 
mussels or scallops. 
 
Lipid composition is presented in table 5 and 6, whereas mean amount of lipids in wet sample 





Table 5 – Main FA composition in raw and prepared mussels and scallops. Composition is expressed as g/100g. # 
n6/n3 is described as a ratio between the two types of FA. * indicates a significant difference between raw mussels and 
raw scallops, † indicates a significant difference between raw scallops and cooked scallops. 
  Blue mussels, raw Blue mussels, cooked Scallops, raw Scallops cooked 
  
FA g/100g lipids 
 SFA 21.4 ± 0.4 21.4 ± 0.4 27.9 ± 2.9 * 28.2 ± 0.4 
MUFA 23.1 ± 0.6 22.5 ± 1.0 9.4 ± 2.6 * 8.6 ± 0.8 
PUFA 45.7 ± 1.3 46.6 ± 2.5 48.3 ± 2.2 * 51.9 ± 0.7 † 
     n3 37.7 ± 0.9 38.7 ± 1.7 48.3 ± 2.1 * 52.0 ± 0.7 † 
Lc-n3 36.4 ± 0.9 37.4 ± 1.7 45.5 ± 2.0 * 49.1 ± 0.9 † 
n6/n3# 1:4 ± 0.2 1:4 ± 0.3 1:20 ± 0.1 * 1:20 ± 0.1 
 




        
 






















Table 7 – Values for IC50 1mU, mussels and scallops freeze dried sample. ¤ indicates significant difference between 
raw and cooked mussels, * indicates a significant difference between raw mussels and raw scallops. 
  Blue mussels, raw 
Blue mussels, 
cooked Scallops, raw Scallops, cooked 
 
IC50 µg/mU 
Freeze dried  4.1 ± 0.2 3.5 ± 0.3 ¤ 2.1 ± 0.5 * 1.9 ± 0.4 
 
 
In mussels there was a significant difference between raw and prepared samples. The 




Water and ash 
 
Different effect from the two types of food preparation techniques was clearly seen, where 
boiling had a larger effect on composition than quick panfrying. Studies looking at grilling of 
other food items has seen a larger change in composition than in this study, but samples are 
usually subjected to higher temperatures and for a longer time than used in this study (Weber, 
Bochi et al. 2008). There was a small, but significant loss of water after preparation of 
scallops. There was a significant difference in ash and AA content between raw and prepared 
scallops in the wet samples, but there was no significant difference between raw and prepared 
dry samples. 
 
The difference in ash content between raw and prepared mussels was not significant in the 
wet samples, in the dry samples there was a significant loss of ash after preparation. When 
comparing mussels and scallops it appears that ash content and water loss during preparation 
was connected. Losses of water lead to a loss of inorganic water soluble compounds (WSC), 
which resulted in a loss of total ash content. Boiling of other types of seafood has been shown 
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to have similar effect, loss of moisture and (WSC) leads to an increase in relative lipid and 




Protein content was higher in scallops than in mussels, this is consistent with data from 
NIFES who state 10 and 18 g/100g protein for mussels and scallops, respectively (Nifes 
2012a; Nifes 2012b). Amount of protein bound AA in dry samples was 288.6 mg/g in raw 
mussels and 368.6mg/g in cooked mussels whilst in scallops protein bound AA was 
515.9mg/g and 529.9mg/g in raw and cooked respectively. Loss of water soluble compounds 
during food preparation means that a higher relative amount of sample will consist of 
insoluble compounds such as protein-bound AA.   
 
Scallops and mussels had similar relative amount of essential and sulfur containing AA. 
Scallops contained more essential AA and sulfur AA per 100g since they have a higher total 
amount of AA. Both species have all eight analyzed essential AA and can therefore be 
considered a high quality protein source. As the ninth AA (tryptophan) is destroyed during 
acid hydrolysis, no results for this AA could be analyzed.  
 
Blue mussels contained a wide variety of free AA. They are commonly consumed as a whole 
organism, and contain a larger variation of AA than food items that mostly consists of muscle 
tissue. The large amount of urea and other waste products not commonly found in muscle are 
other signs that the AA are from a whole organism. In wet sample there was approximately 
1.2g urea per 100 g edible raw mussels, and 1.0g per 100g cooked mussels. Preparation of 
blue mussels led to a loss of most of the free AA, and an increase in total AA in dry samples. 
The total AA is mostly bound in muscle tissue and organs so the increase is likely to be due to 
loss of water during preparation. Loss of water and WSC such as free AA are observed in 
other marine food items (Chiou, Tsai et al. 2004) 
 
FAA from scallops consists mainly of glycine and taurine, some arginine and small amounts 
of alanine. Scallops contain more protein, total AA, free AA and taurine than mussels, a 
difference that was significant when comparing the raw samples. Glycine and taurine have 
been shown to be important for osmoregulation in other bivalves and are probably important 
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for osmoregulation in scallops (Hosoi, Kubota et al. 2003). Scallops contained more taurine 
than mussels and the amount was not affected by preparation. The preparation of scallops led 
to little loss of water which may explain the good retention of taurine. Loss of glycine and 
taurine is observed in other processing methods used on seafood (Larsen, Stormo et al. 2007). 
 
There are several possible explanations for the low protein content in mussels found in this 
study compared to other studies. One is methodical differences. The most commonly used 
method for protein determination is the Kjeldahl method based on total nitrogen. As mussels 
contain a large amount of non-protein nitrogen (i.e. FAA and urea), a method based on 
analysis of total nitrogen would probably over-estimate the protein content. Another possible 
explanation is seasonal variation. In blue mussels nitrogen excretion peaks prior to spawning, 
and declines during fall and early winter. Stress, food availability and salinity will also affect 
utilization of protein reserves (Elizabeth 2007). Bivalves have poor ability to change 
intracellular levels of fluid, and must therefore adjust cellular volume by changing the 
concentration of certain amino acids and other small molecules. As direct uptake of FAA is 
limited the main source of FAA is whole body protein. Changes in salinity can lead to a major 
loss of nitrogen, and may lead to stress and increased mortality in a bivalve population 
(Elizabeth 2007). Other species of bivalve mollusks are known to lose large amounts of 
protein after spawning, and will rebuild the nitrogen storages during the fall and winter (Davis 




When calculated for water loss mussels and scallops contained around 500 and 1000 mg 
taurine respectively per 100 g edible tissue; a 100g serving would provide far more taurine 
than what is normally consumed in an average Western diet. The amounts found in this study 
correspond well other studies investigating taurine content in food (Laidlaw, Grosvenor et al. 
1990; Dragnes, Larsen et al. 2009; Wójcik, Koenig et al. 2010). Taurine content in dry 
samples decreased significantly after steaming of blue mussels, and was not affected by frying 
of scallops. In wet samples the relative taurine content increased in both species due to loss of 




Marine bivalves are generally the food group containing the highest amount of taurine 
(Simpson, Allen et al. 1959; Allen 1961). Taurine and other free amino acids are used for 
osmoregulation and taurine content will therefore depend on the mollusk growth conditions 
such as salinity (Zurburg and De Zwaan 1981; Burg and Ferraris 2008). 
 
Average intake of taurine varies greatly depending on diet. One British study estimated the 
average daily intake to be around 58mg/day for non-vegans, while an American study 
estimated average intake among non-vegans to be 123mg/day (Rana and Sanders 1986; 
Stapleton, Charles et al. 1997). There is no recommended daily intake for taurine. 
 
Taurine has shown beneficial effects in the prevention of stroke and CVD in SHR and stroke 
prone hypertensive rats (SHRSP). Feeding the SHRSP taurine-rich fish protein in a salt 
reduced diet resulted in a reduction in BP and incidence of stroke decreased from 80 to 10 
percent. (Yamori, Taguchi et al. 2010). These findings are supported by other SHR studies 
(Nandhini and Anuradha 2004; Hu, Xu et al. 2009), and studies on fructose induced 
hypertension in rat models (Rahman, Park et al. 2011). There are different suggestions for BP 
lowering mechanisms of taurine. Production of NO, increased kallikrein system activity, 
reduction in epinephrine and norepinephrine and indirect improvement by improving glucose 
metabolism are mechanisms that have been suggested (Anitha Nandhini and Anuradha 2002; 
Wójcik, Koenig et al. 2010).  
 
A study comparing two Japanese populations of Okinawan ancestry, one in Japan and one in 
Brazil, revealed a higher rate of obesity and hypertension in the Brazilian population. Fish 
intake, taurine excretion, and plasma EPA and DHA were far lower in the Brazilian 
population (Moriguchi, Moriguchi et al. 2004). Other epidemiological studies have shown an 
inverse relationship between urinary taurine excretion and CVD risk and mortality (Yamori, 
Liu et al. 2009). In female Japanese high school students higher intakes of taurine was 
associated with lower levels of plasma glucose and an improved lipid profile (Ishikawa, Arai 







Lipid content in bivalves varies seasonally and depends on food availability, reproductive 
status and growth. Spawning especially has a large impact on lipid levels as lipids are used in 
the production of eggs that are released in the water, resulting in a loss of lipids (Narváez, 
Freites et al. 2008).  
 
Average amount of lipids per 100g blue mussels was 1.3 g and 1.8 g in raw and prepared 
mussels, respectively. This is consistent with values of 1g/100g from NIFES (2012a). Lipid 
content in scallops was lower than expected when compared to values from NIFES 1g/100g 
(2012b). This might be due to varying lipid-content as a result of gametogenesis as all shells 
contained roe. In other species of scallops, gonad size is inversely related to lipid content in 
muscle. The lowest lipid amount (0.36 g/100g) for this species was observed close to 
spawning (Beltrán-Lugo, Maeda-Martínez et al. 2006). This is supported by observations of 
increased lipid content in gonads in Pecten maximus near spawning (Pazos, Román et al. 
1997). Although some individual FAs changed significantly after processing there was no 
difference in saturated, monounsaturated or polyunsaturated fat between raw and prepared 
mussels. In scallops EPA and DHA was significantly increased after processing, which 
resulted in a significant increase in PUFA, n-3 and LC-PUFA when comparing raw and 
prepared samples. Saturated and monounsaturated fat was not affected by preparation. The 
change in individual FAs was small in both species and could be a result of the small sample 
size used in this study. There was a significant difference between raw mussels and raw 
scallops for all major groups of FAs.  
 
The high amount of EPA and DHA in mussels was typical for fat profiles of food from marine 
sources. 37 % of FA in mussels was n-3, with EPA being the biggest contributor. FA 
composition is also consistent with NIFES (2012a). One exception is EPA and DHA 
composition, EPA was higher and DHA was lower in this study compared to NIFES data, 
total amount of n-3 was similiar.  
 
The lipid profile in scallops was typical of marine species, with EPA and DHA contributing to 
about 45 percent of the total FA. The percent of DHA was very high at 27%. Lipid 
composition in scallops varies seasonally. The highest levels of PUFA are found during 
sexual maturity in June-July, which coincides with the biggest algae bloom. (Besnard, Lubet 
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et al. 1989). Most of the individual shells in this paper had roe, which is expected since 
scallops spawn in the late fall in Norway. This could explain the relatively high relative 
amount of PUFA found in this study, as well as the low lipid content. Other studies support 
the observation that there is a selective incorporation of certain FAs in eggs of scallops, but 
also notes that diet has a great influence on FA composition (Pazos, Román et al. 1997).   
 
A 100g serving of prepared scallops would provide 111mg EPA and 164mg DHA, while an 
equivalent serving of prepared mussels would provide 417mg EPA and 230mg DHA. Despite 
scallops having a relative higher amount of total FA as n-3 PUFA, mussels is a better source 
of n-3 PUFA as they contain more fat. Both mussels and scallops can be considered a good 
sources of EPA+DHA as a 100g serving would satisfy daily requirements.  
 
A minimum of 250 mg EPA + DHA per day is advised. For people with coronary heart disease 
and for secondary prevention of myocardial infarction approximately 1 g EPA + DHA per day 
is recommended (Elmadfa and Kornsteiner 2009). For prevention against hypertension the 
recommended amount may be even higher. With some sources claiming that around 3 grams 
are needed to have an significant effect (Campbell, Dickinson et al. 2012). This is supported 
by studies investigating hypertriglyceridemia where the recommended amount is 2-4 g/day 




Preparation significantly improved the IC50 value of mussels, but did not affect scallops 
significantly. Scallops had better ACE inhibition per gram sample, but also contained more 
protein per gram. Raw scallops had on average more than twice as much protein as raw 
mussels. The IC50 value for raw scallops was almost half of the IC50 of raw mussels. When 
IC50 value per mg protein was calculated the difference between samples was not significant. 
It appears that the most important factor for ACE inhibition in this study was the amount of 
protein. This is consistent with studies on cod muscle, which show an increase in ACEI 
activity after heat treatment and enzymatic hydrolysis. But no difference between samples 




However, in this the amount and composition of peptides formed as a result of the enzymatic 
hydrolysis was not determined. It is therefore not possible to determine whether one of the 
species contains more potent ACEI peptides than the other. The use of different cooking 
methods and large difference in protein content between species makes it hard to compare 
blue mussels to scallops in regard to ACE-inhibition. 
 
Effects of ACE-inhibitors on animal and human models 
 
While in vitro experiments are useful in the search for biologically active compounds, it’s not 
certain that the results can be reproduced in in vivo experiments. Much work has been done on 
antihypertensive peptides in both animal and human studies. Spontaneously hypertensive rats 
are commonly used to evaluate the effect of antihypertensive peptides. Several studies have 
shown antihypertensive effects of peptides in rat models (Liu, Tung et al. 2011). Animal 
studies have also shown that lactopeptides pass the gastrointestional barrier and accumulate in 
organs (Masuda, Nakamura et al. 1996). The lowest dose with an observed effect in human 
subjects with mild hypertension was 3.07mg/d lactotripeptides. SBP was lowered 4.4 mmHg 
and DBP was lowered by 2.8 mmHg after 10 weeks compared to a placebo drug. As much as 
52.5 mg/day was used in a safety study, SBP decreased by 4.1 mmHg and DBP decreased by 
1.8 mmHg. A clear dose-effect relationship has not been discovered (Boelsma and Kloek 
2009). In some human trials VPP and IPP has shown promising results (Seppo, Jauhiainen et 
al. 2003; Nakamura, Mizutani et al. 2011; Turpeinen, Ehlers et al. 2011), while other studies 
have shown no effect. 
 
Two recent studies tested the effect of IPP and VPP on hypertensive subjects in Denmark and 
the Netherlands, and no effects on BP were found. Lack of effect in these populations could 
be due to genetics or diet, and it is possible that the high consumption of dairy in these 
countries might limit the effect of dairy derived peptides (Engberink, Schouten et al. 2008; 
Usinger, Jensen et al. 2010). While several human studies have promising results there are 
conflicting results. There might be a large variation between populations with regards to 
effect of ACE-inhibitors. In a meta-analysis it was found that the effect of IPP and VPP was 
more evident in Asian subjects than Caucasian (Cicero, Gerocarni et al. 2010). Difference in 
in vitro and in vivo effects might be due to gastrointestinal degradation of the peptide and 
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factors preventing the peptide reaching the target organ (Martinez-Maqueda, Miralles et al. 
2012).   
 
ACE-inhibitory peptides have been isolated from a number of marine sources, both from 
muscle protein and waste products. Salmon, sardine, bonito, tuna, Pollock sea bream, pelagic 
thresher, fish sauce and yellowfin sola have all shown ACE-inhibition in vitro. One of the 
most potent ACE-inhibitor found in fish was a tripeptide isolated from bonito with a IC50 
value of 0,32 µM. (Howell and Kasase 2010) The ultrafiltrate of dried bonito was also able to 
reduce BP in 62% of borderline and mildly hypertensive subjects using 1,5 g/d (Fujita, 
Yamagami et al. 2001). Sardine peptides was effective at reducing BP and improved glucose 
tolerance by improving insulin sensitivity in SHR models (Otani, Ninomiya et al. 2009). The 
tripeptide Leu–His–Pro was isolated from shrimp (Acetes chinensis) protein. The peptide was 
tested on SHR and was found to have a strong antihypertensive effect. SBP was reduced by 
31 and 18 mmHg using dosages at 6mg/kg and 2mg/kg respectively (Cao, Zhang et al. 2010). 
 
Recently peptides from jellyfish peptides (JPC) were administered to renovascular 
hypertensive rats (RVH). SBP and DBP were significantly reduced in the hypertensive rats, 
while there was no effect on BP in normotensive rats. Earlier tests has determined the IC50 
value of JPC to be 43 µg/ml. Measurements of AngII showed no changes in plasma 
concentration, but concentration of AngII in kidneys decreased significantly (Zhuang, Sun et 
al. 2012). A Dutch study found a significant reduction in BP with intake of milk containing 
lactotripeptides, but no effect on plasma ACE (van der Zander, Jakel et al. 2008). As 
mentioned previously this result can occur from a RAAS activity reduction in various organs, 
which can happen without reducing plasma RAAS activity (Geleijnse and Engberink 2010). 
Different ACEI peptides have varying affinity for certain organs in the body.  They can 
therefore have a antihypertensive effect by reducing AngII activity in kidneys, without having 
any effect on plasma ACE (Zhuang, Sun et al. 2012).  
 
A study on marine collagen peptides on Chinese subjects showed a significant reduction in 
DBP and SBP compared to controls. Renal function, insulin sensitivity, glucose and lipid 
metabolism also seemed to improve in the group receiving the peptides. The subjects tested 




Several studies in rats have shown a strong anti-hypertensive effect of ACE-inhibitory 
peptides. In humans the results have been more uncertain, ranging from a strong 
antihypertensive effect to none at all. The influence of genetics and diet is unknown. Further 
research is needed to investigate a difference in effect between populations, and mechanisms 
to explain such an effect 
Conclusion 
 
Changes in proximate composition were clearly affected differently by the two preparation 
methods. Quick panfrying of scallops had little effect on AA, lipids, water and ash. Normally 
one would use butter or oil, which might have given a different result. Blue mussels were 
affected by steaming which led to a loss of water, ash and some free AA. This resulted in an 
increase in lipids and protein bound AA per 100 grams. 
 
Both species have a good lipid profile with high relative amount of n-3 PUFA, although the 
total amount of fat was relatively low. Around 100g fried scallops or 50 g cooked mussels are 
needed to satisfy daily marine n-3 PUFA requirements for most individuals.  
 
The amount of taurine in both species was very high and could possibly be a component of a 
diet that has the goal of reducing hypertension.  
 
There was ACE-inhibiting activity found in both species. Scallops had the best ACE-
inhibitory activity and this was not affected by food preparation methods. Mussels had a 
lower inhibitory effect, but cooking improved the activity. However when considering the 
protein content both species performed equally well and there was no significant 
improvement after preparation. It’s difficult to predict what, if any, effect the ACE-inhibitors 
present could have in vivo as this depends on several variables. Identifying the various 
fractions with ACE-inhibiting activity and animal studies are needed to identify the usefulness 
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